A similar sequence of CSF Aβ42, T‐tau, and P‐tau changes has also recently been demonstrated in the Alzheimer's Disease Neuroimaging Initiative (ADNI) using longitudinal Aβ PET to estimate the time course of disease (Insel P et al, under review). This evidence concerns the gene MAPT and Alzheimer disease.